Diagnosis and treatment pathway of neoadjuvant immunotherapy for esophageal cancer in Henan province
- VernacularTitle:河南省食管癌新辅助免疫治疗诊疗路径
- Author:
Li WEI
1
;
Wenqun XING
2
;
Yang YANG
3
Author Information
1. Department of Thoracic Surgery, Henan Provincial People s Hospital, Zhengzhou, 450003, P. R. China
2. Department of Thoracic Surgery, Henan Cancer Hospital, Zhengzhou, 450003, P. R. China
3. Department of Thoracic Surgery, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, 450052, P. R. China
- Collective Name:representatives of the Writing Group of Diagnosis and Treatment Pathway of Neoadjuvant Immunotherapy for Esophageal Cancer in Henan province
- Publication Type:Journal Article
- Keywords:
Esophageal cancer;
neoadjuvant;
immunotherapy;
diagnosis and treatment pathway
- From:
Chinese Journal of Clinical Thoracic and Cardiovascular Surgery
2024;31(02):186-195
- CountryChina
- Language:Chinese
-
Abstract:
Esophageal cancer is a highly prevalent tumor species in Henan province, which brings heavy medical burden to families and society. Surgical treatment plays a dominant role in the treatment of non-advanced esophageal cancer. However, cancer cells in esophageal cancer lesions are highly invasive, postoperative recurrence and metastasis rates are pretty high. More effective systemic and comprehensive treatment is urgently needed to improve the prognosis. We invited 52 doctors in esophageal surgery, oncology, pathology, imaging, and radiation therapy of 32 hospitals at all levels in Henan province, to repeatedly negotiate and fully discuss in combination with evidence and clinical practice experience. Finally, “diagnosis and treatment pathway of neoadjuvant immunotherapy for esophageal cancer in Henan province” was formulated. In this treatment pathway, seven recommendations were proposed from seven perspectives including target population, patient evaluation, protocol selection, surgical timing, postoperative management, organ preservation, and general principles to offer reference for medical personnel related to esophageal cancer surgery.
